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6. Public health. The public health impact is 
unknown due to insufficient evidence regarding 
the effectiveness of psychiatric eConsults for 
mental health treatment for children and 
pregnant and postpartum persons.  
7. Long-term impacts. The long-term impacts on 
cost, utilization, and mental health are 
unknown. 
 
CONTEXT 
It is estimated that 14%–20% of California’s children and 
20% of pregnant and postpartum persons may need care 
for a behavioral health condition.1 While behavioral health 
encompasses both mental health and substance use 
disorders, AB 1676 focuses on mental health disorders. 
Some of the most common chronic conditions in children 
are depression/anxiety disorders, autism spectrum 
disorders, and attention-deficit/hyperactivity disorder 
(ADHD). Maternal mental health (MMH) disorders include 
a range of distinct disorders that may arise or become 
exacerbated during pregnancy or after birth — depression 
and anxiety are two of the most common MMH disorders. 
Primary care providers (PCPs) often assume full 
responsibility for treating their patient’s mental health 
conditions due to a lack of available resources. Telehealth 
consultations have been introduced as one way to 
address this lack of resources.  
 
AT A GLANCE 
The version of California Assembly Bill 1676 analyzed 
by CHBRP would require that health plans and 
insurers establish a telehealth consultation program by 
January 1, 2021, “that provides providers who treat 
children and pregnant and postpartum persons with 
access to a psychiatrist during standard provider 
hours.” 
1. CHBRP estimates that, in 2021, all 24.5 
million Californians enrolled in state-regulated 
health insurance, including enrollees in Medi- 
Cal Managed Care Plans, will have insurance 
subject to AB 1676. 
2. Benefit coverage. Currently, 74% of 
enrollees with health insurance that can be 
subject to state mandates and 38% of 
enrollees with Medi-Cal MCP coverage 
subject to AB 1676 are enrolled in plans or 
policies where providers have access to a 
telepsychiatry consultation program, known as 
a psychiatry “eConsult” program.  
3. Utilization. CHBRP did not model utilization 
changes because the bill relates to a program 
for providers, not a benefit for enrollees. 
Estimates of current utilization of psychiatric 
eConsults are not available given limitations in 
coding and data sources.  
4. Expenditures. CHBRP assumes there will be 
increased administrative costs associated with 
the implementation of AB 1676, as well as an 
increase in overall utilization of psychiatric 
services. However, the expenditure impact  
cannot be estimated. 
5. Medical effectiveness. There is limited 
evidence on the effectiveness of psychiatric 
eConsults generally and insufficient evidence 
on the effectiveness of psychiatric eConsults 
specifically for children and pregnant and 
postpartum persons. 
 
In this report, provider-to-provider telehealth 
consultations are referred to as electronic 
consultations or “eConsults”, and include both 
synchronous (e.g., phone, videoconference) and 
asynchronous (e.g., email, electronic health 
record/EHR) modalities. A patient may or may not 
be present during an eConsult. A telehealth 
consultation solely between a provider and a 
patient is not included in this definition. 
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When a PCP experiences difficulty in treating mental 
health conditions or referring patients for specialty mental 
health care for problems that are often first encountered 
and addressed in a primary care setting, a PCP may 
request an eConsult with a psychiatrist or mental health 
provider. 
 
BILL SUMMARY  
AB 1676 would require that health plans and insurers 
establish a telehealth consultation program by January 1, 
2021, “that provides providers who treat children and 
pregnant and postpartum persons with access to a 
psychiatrist during standard provider hours.” The stated 
purpose of the bill is to more quickly diagnose and treat 
children and pregnant and postpartum persons suffering 
from mental illness. The bill would also require plans and 
insurers to: 
• Communicate information about the program and 
its availability to contracting medical providers 
who treat children and pregnant and postpartum 
persons at least twice a year in writing; and 
• Maintain records and data on the utilization of its 
telehealth consultation program and the 
availability of psychiatrists to facilitate ongoing 
changes and improvements to the program. 
Figure A shows how many Californians have health 
insurance that would be subject to AB 1676. 
Figure A. Health Insurance in CA and AB 1676 
 
Source: California Health Benefits Review Program, 2019. 
Notes: *Medicare beneficiaries, enrollees in self-insured products, etc. 
 
 
IMPACTS 
Benefit Coverage, Utilization, and Cost  
CHBRP did not model benefit changes because the bill 
does not require coverage of a benefit available to 
enrollees but rather requires insurers to make a 
psychiatric eConsult program available to PCPs. Similarly, 
CHBRP did not model an effect in terms of utilization or 
expenditures. 
Benefit Coverage 
Currently, 74% of enrollees with health insurance that can 
be subject to state mandates and 38% of enrollees with 
Medi-Cal MCP coverage subject to AB 1676 are already 
enrolled in health plans or policies with a psychiatric 
eConsult program. 
Postmandate, CHBRP assumes that health plans and 
insurers without psychiatric eConsult programs will need 
to establish one. Health plans and insurers could provide 
a telepsychiatry consultation program for PCPs through a 
third-party vendor, in-network psychiatrists, or some other 
approach. 
Utilization 
Estimates of current utilization of psychiatric eConsults are 
not available given limitations in coding and data sources. 
As a result of AB 1676, more enrollees with mental health 
care needs may have increased access to psychiatric 
services including medications and psychotherapy through 
their PCPs as a result of a psychiatric eConsult program, 
but CHBRP is not able to quantify these impacts. 
Expenditures 
CHBRP estimates AB 1676 would result in increases in 
administrative costs. As an example, a psychiatry 
consultation program in Massachusetts that PCPs can 
access by phone costs the state about $850,000 per year. 
The implementation of AB 1676 could create a shift in 
utilization from in-person patient consultations or provider-
to-patient telehealth consultation to eConsults. It could 
also increase the referrals of patients to psychiatrists, 
which will increase overall utilization of psychiatric 
services. If that happens, it may impact overall cost; 
however, the magnitude of the effect is unknown.  
Medi-Cal 
COHS, Not 
Subject to 
Mandate 
1,603,000
Medi-Cal 
FFS, Not 
Subject to 
Mandate 
1,351,000
Insured, Not 
Subject to 
Mandate* 
8,222,000
Uninsured 
3,982,000
CDI-Reg 
528,000
DMHC-Reg (Not 
Medi-Cal) 
16,371,000
DMHC-Reg 
(Medi-Cal) 
7,591,000
State-
regulated 
health 
insurance 
subject to 
Mandate
24,490,000
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Medi-Cal 
CHBRP estimates that AB 1676 would increase providers’ 
access to specialists proportionally more for Medi-Cal 
beneficiaries compared to commercial plan enrollees, as 
74% of commercial and CalPERS enrollees and 38% of 
Medi-Cal Managed Care enrollees are covered by plans 
and insurers that already have a psychiatric eConsult 
program in place. 
Mandates such as AB 1676 that impact Medi-Cal more 
significantly may lead to differences in the coverage and 
utilization of certain services for these beneficiaries; 
therefore, it may disproportionately affect the Latino, 
African American, or Other racial/ethnic population if the 
mandate-relevant service is found to be medically 
effective. 
CalPERS 
CHBRP does not expect impacts for CalPERS enrollees 
to be different from the impacts to enrollees in other 
commercial plans or policies.  
Number of Uninsured in California 
As described above, CHBRP did not estimate impacts on 
premiums and is therefore unable to determine whether 
there would be an impact on the number of uninsured.  
Medical Effectiveness  
CHBRP identified no rigorous studies that addressed the 
use of psychiatric eConsult programs to treat the specific 
populations specified in AB 1676. An analysis of studies of 
psychiatric eConsult programs for adults in general is 
provided, in order to provide some context on 
effectiveness.  
CHBRP found limited evidence on the effectiveness of 
psychiatric eConsults generally and insufficient evidence 
on the effectiveness of psychiatric eConsults specifically 
for children and pregnant and postpartum persons.  
Specifically, there is limited evidence that psychiatric 
eConsults are effective at improving appropriate treatment 
of mental health conditions as measured by improvement 
in the receipt of more appropriate care, mental health 
outcomes in patients, provider knowledge and skill 
development for mental health treatment, provider 
satisfaction, and timeliness of services.  
Public Health 
In the first year postmandate, the impacts of AB 1676 on 
public health and disparities in health outcomes are 
unknown due to insufficient evidence regarding the 
effectiveness of psychiatric eConsults for mental health 
treatment for children and pregnant and postpartum 
persons. As noted above, there is limited evidence 
suggesting that psychiatric eConsults for the adult 
population overall are effective. It stands to reason that 
the populations specified in AB 1676 would experience the 
same effectiveness of psychiatric eConsults as the 
general population. 
Incorporating telepsychiatry consultations for PCPs who 
treat children and pregnant and postpartum persons could 
potentially increase access and timeliness to appropriate 
mental health care. It is estimated that this change in 
access would be greatest for rural beneficiaries who may, 
directly or through their PCP, otherwise not have had their 
mental health concerns addressed by a psychiatrist due to 
shortages of licensed psychiatrists in rural areas.  
Long-Term Impacts 
The potential long-term impacts of AB 1676 on cost, 
utilization, and mental health are unknown. Mental health 
conditions in the population overall contribute to general 
economic loss, although it is difficult to estimate losses for 
these specific populations and conditions. 
The literature reviewed for this analysis suggests that 
there is the potential for PCPs to increase knowledge and 
skills over time with regard to diagnosis and treatment of 
mental health conditions. Therefore, it is plausible that 
over time these providers may be better prepared to 
advise their patients after obtaining regular access to 
psychiatrists for consultation, resulting in the potential for 
more prompt diagnosis and treatment, and improved 
patient and provider satisfaction. Further, the literature 
also indicates that after consultation with psychiatrists, a 
large proportion of mental health diagnoses and treatment 
plans may be corrected. This has the potential to impact 
patient mental health outcomes immediately and over 
time. 
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Essential Health Benefits and the 
Affordable Care Act 
AB 1676 would not require coverage for a new state 
benefit mandate that appears to exceed the definition of 
essential health benefits (EHBs) in California because it 
requires plans to establish a telepsychiatry consultation 
program for providers and is not a benefit for enrollees. 
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The California Health Benefits Review Program (CHBRP) was established in 2002. As per its authorizing 
statute, CHBRP provides the California Legislature with independent analysis of the medical, financial, 
and public health impacts of proposed health insurance benefit-related legislation. The state funds 
CHBRP through an annual assessment on health plans and insurers in California.  
An analytic staff based at the University of California, Berkeley, supports a task force of faculty and 
research staff from multiple University of California campuses to complete each CHBRP analysis. A 
strict conflict-of-interest policy ensures that the analyses are undertaken without bias. A certified, 
independent actuary helps to estimate the financial impact. Content experts with comprehensive 
subject-matter expertise are consulted to provide essential background and input on the analytic 
approach for each report.  
More detailed information on CHBRP’s analysis methodology, authorizing statute, as well as all 
CHBRP reports and other publications are available at www.chbrp.org. 
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POLICY CONTEXT 
The California Assembly Committee on Health has requested that the California Health Benefits Review 
Program (CHBRP)2 conduct an evidence-based assessment of the medical, financial, and public health 
impacts of Assembly Bill (AB) 1676, Health Care: Mental Health. 
Bill-Specific Analysis of AB 1676, Health Care: Mental Health 
Bill Language Summary 
AB 1676 would require health plans and insurers to establish a telehealth consultation program by 
January 1, 2021, “that provides providers who treat children and pregnant and postpartum persons with 
access to a psychiatrist during standard provider hours.” The stated purpose of the bill is to more quickly 
diagnose and treat children and pregnant and postpartum persons suffering from mental illness. The bill 
would also require plans and insurers to: 
• Communicate information about the program and its availability to contracting medical providers 
who treat children and pregnant and postpartum persons at least twice a year in writing; and  
• Maintain records and data on the utilization of its telehealth consultation program and the 
availability of psychiatrists to facilitate ongoing changes and improvements to the program.  
The full text of AB 1676 can be found in Appendix A. 
Relevant Populations 
If enacted, AB 1676 would affect the health insurance of approximately 24.5 million enrollees (61.8% of 
all Californians). This represents 100% of the 24.5 million Californians who will have health insurance 
regulated by the state that may be subject to any state health benefit mandate law — health insurance 
regulated by the California Department of Managed Health Care (DMHC) or the California Department of 
Insurance (CDI). This includes enrollees in Medi-Cal Managed Care Plans (MCPs). 
Interaction With Existing Requirements 
Health benefit mandates may interact and align with the following state and federal mandates or 
provisions. 
California Policy Landscape 
California law and regulations 
Mental health-related mandates 
There are currently 12 state benefit mandates3 related to screening, diagnosis, and/or treatment for 
mental health conditions. AB 1676 requires plans and insurers to establish a telehealth psychiatry (i.e., 
                                                     
2 CHBRP’s authorizing statute is available at http://www.chbrp.org/about_chbrp/index.php.  
3 A list of current health insurance benefit mandates in California state and Federal law is available under 
“Resources” at http://chbrp.com/other_publications/index.php.  
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telepsychiatry) consultation program for providers and does not require plans and insurers to provide 
telehealth services directly to patients; therefore, AB 1676 is not expected to interact with any of the 
mental health mandates in the immediate future. 
Recent related mental health legislative activity 
AB 2193 Maternal Mental Health. AB 2193 (Maienschein. Maternal Mental Health, enacted 2018) 
required health plans and insurers to develop a maternal mental health (MMH) program designed to 
promote quality and cost-effective outcomes, and that the program be developed consistent with sound 
clinical principles and processes.4 AB 2193 required licensed health care practitioners who provide 
prenatal or postpartum care for a patient to ensure mothers are appropriately screened for MMH 
conditions. 
California Task Force on the Status of Maternal Mental Health Care. In 2014, the California 
Legislative Women’s Caucus introduced Assembly Concurrent Resolution (ACR) 148 to explore 
untreated MMH disorders and their impacts (CA Task Force, 2017). The resolution passed and initiated a 
multidisciplinary Task Force representing stakeholders in mental health, medicine, public health, nursing, 
research, insurance, and hospitals. From 2015 to 2016, the California Task Force on the Status of 
Maternal Mental Health Care (the Task Force) examined existing barriers to screening and diagnosis, 
current treatment options, evidence-based treatments, and emerging treatments (CA Task Force, 2017). 
In December 2016, the Task Force published “California’s Strategic Plan: A catalyst for shifting statewide 
systems to improve care across California and beyond.” The report included an overview of the current 
state and recommendations for California to improve maternal mental health care (CA Task Force, 2017). 
Perinatal Depression Awareness Month. In 2010, California designated May as Perinatal Depression 
Awareness Month.5 The resolution also requested that several stakeholders including the Department of 
Health Care Services (DHCS), California Department of Public Health, First 5 California, the American 
College of Obstetricians and Gynecologists (ACOG), and Postpartum Support International work together 
on several issues. The ACR encouraged these stakeholders to explore ways to improve women’s access 
to mental health care, increase awareness and education about perinatal depression, encourage the use 
of screening tools, and improve the availability of effective treatment options and community support 
services.6 
CHBRP found no proposed legislation in California relevant to the telepsychiatry consultation program for 
providers.  
Other States 
CHBRP is not aware of similar benefit mandates in any other states requiring plans or insurers to 
establish a telepsychiatry consultation program for providers. However, Massachusetts passed legislation 
that provides state funding for a program that includes a psychiatric phone consultation program for 
providers who treat children and pregnant and postpartum women, as described below.  
Funded by a legislative appropriation in the Department of Mental Health budget, the Massachusetts 
Child Psychiatry Access Project (MCPAP) was established in 2004.7 MCPAP is a system of regional 
                                                     
4California Health and Safety Code 1367.625; California Insurance Code 10123.867. 
5 California ACR (2010), available online at 
https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=200920100ACR105. 
6 California Assembly Concurrent Resolution 105 (Resolution Chapter 9 of the Statutes of 2010). 
7 Chapter 149 in the Acts of 2004. Available online at 
https://malegislature.gov/Laws/SessionLaws/Acts/2004/Chapter149. 
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children’s psychiatric consultation teams designed to improve access to treatment for children with 
behavioral health problems. MCPAP seeks to strengthen pediatric primary care providers’ (PCPs) ability 
to screen, diagnose, and treat children with mild to moderate behavioral health problems (e.g., anxiety, 
depression, ADHD) in primary care. It also supports PCPs in referring children with more serious 
behavioral health problems to appropriate psychiatric specialty care. 
In 2010, Massachusetts passed the Postpartum Depression Act. The law established a Special 
Legislative Commission on postpartum depression to assess current research and evaluate the state’s 
current practices.8 The law also established postpartum depression screening regulations and authorized 
funding to expand the MCPAP to MCPAP for Moms, which uses a multipronged approach to help 
providers identify and treat postpartum depression, including: 
• Training and toolkits about depression screening and assessment informed by evidence-based 
guidelines; 
• Psychiatric phone consultation for health care providers caring for pregnant and postpartum 
women; and 
• Care coordination that links women to psychotherapy and support groups (Byatt et al., 2016). 
Federal Policy Landscape 
Affordable Care Act 
Essential Health Benefits 
State health insurance marketplaces, such as Covered California, are responsible for certifying and 
selling qualified health plans (QHPs) in the small-group and individual markets. QHPs are required to 
meet a minimum standard of benefits as defined by the ACA as essential health benefits (EHBs). In 
California, EHBs are related to the benefit coverage available in the Kaiser Foundation Health Plan Small 
Group Health Maintenance Organization (HMO) 30 plan, the state’s benchmark plan for federal EHBs.9,10 
States may require QHPs to offer benefits that exceed EHBs.11 However, a state that chooses to do so 
must make payments to defray the cost of those additionally mandated benefits, either by paying the 
purchaser directly or by paying the QHP.12,13 State rules related to provider types, cost-sharing, or 
                                                     
8 Massachusetts House bill 4859; Chapter 313 in the Acts of 2010. Available at: 
https://malegislature.gov/Laws/SessionLaws/Acts/2010/Chapter313. 
9 The U.S. Department of Health and Human Services (HHS) has allowed each state to define its own EHBs for 2014 
and 2015 by selecting one of a set of specified benchmark plan options. CCIIO, Information on Essential Health 
Benefits Benchmark Plans. Available at: https://www.cms.gov/cciio/resources/data-resources/ehb.html.  
10 H&SC Section 1367.005; IC Section 10112.27. 
11 ACA Section 1311(d)(3). 
12 State benefit mandates enacted on or before December 31, 2011, may be included in a state’s EHBs, according to 
the U.S. Department of Health and Human Services (HHS). Patient Protection and Affordable Care Act: Standards 
Related to Essential Health Benefits, Actuarial Value, and Accreditation. Final Rule. Federal Register, Vol. 78, No. 37. 
February 25, 2013. Available at: www.gpo.gov\fdsys\pkg\FR-2013-02-25\pdf\2013-04084.pdf. 
13 However, as laid out in the Final Rule on EHBs HHS released in February 2013, state benefit mandates enacted 
on or before December 31, 2011, would be included in the state’s EHBs and there would be no requirement that the 
state defray the costs of those state mandated benefits. For state benefit mandates enacted after December 31, 
2011, that are identified as exceeding EHBs, the state would be required to defray the cost. 
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reimbursement methods would not meet the definition of state benefit mandates that could exceed 
EHBs.14  
California’s health care regulators (CDI and DMHC) agree that AB 1676 would not require coverage for a 
new state benefit mandate that appears to exceed the definition of EHBs in California. This is because AB 
1676 requires plans to establish a telepsychiatry consultation program for providers and is not a benefit 
for enrollees. 
Analytic Approach and Key Assumptions 
For the purposes of this analysis, CHBRP has assumed the following:  
• The bill applies to primary care providers who treat: (1) children for all mental health 
conditions, and (2) pregnant and postpartum persons for all mental health conditions.  
• Mental health conditions: Mental health conditions for children and pregnant and postpartum 
persons encompass a range of conditions and levels of severity. However, most research 
literature identifying mental health conditions for these groups focuses on anxiety and depression 
in children and adults, as well as autism spectrum disorder (ASD) and attention-deficit/ 
hyperactivity disorder (ADHD) in children.  
For the purposes of this analysis, CHBRP has assumed that AB 1676 would be applicable to all DMHC- 
regulated plans (including Medi-Cal MCPs) and CDI-regulated policies as of January 1, 2021.  
 
  
 
 
 
                                                     
14 Essential Health Benefits. Final Rule. A state’s health insurance marketplace would be responsible for determining 
when a state benefit mandate exceeds EHBs, and QHP issuers would be responsible for calculating the cost that 
must be defrayed. 
An important note on terminology:  
 
In this report, provider-to-provider telehealth consultations are referred to as electronic 
consultations or “eConsults”, and include both synchronous (e.g., phone, videoconference) and 
asynchronous (e.g., email, electronic health record/EHR) modalities. A patient may or may not be present 
during an eConsult. A telehealth consultation solely between a provider and a patient is not included in this 
definition. 
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BACKGROUND ON MENTAL HEALTH AND TELEHEALTH 
CONSULTATIONS 
This section provides context for the potential impacts of AB 1676 by describing telehealth consultations 
for primary care providers (PCPs) and the mental health disorders in children and pregnant and 
postpartum persons for which these consultations may be sought. Given the wide range of conditions and 
the short timeframe for the report, this background only describes the most common mental health 
conditions for each population AB 1676 specifies. Screening, diagnosis, and psychiatric treatments are 
described, as well as disparities and social determinants of health for these disorders in California.  
Telehealth Consultation for Primary Care Providers 
Often in rural or remote areas, PCPs assume full responsibility for treating their patients’ mental health 
conditions due to a lack of available resources (Fleury et al., 2012; Wright et al., 2005). Telehealth 
consultations (referred to in this report as electronic consultations or “eConsults”) have been introduced 
as one way to address this lack of resources by enabling consultations between specialists at a distance 
and PCPs. AB 1676 only addresses consultations between two health care providers (e.g., a psychiatrist 
and a PCP) and does not include services provided directly to patients. In a review of 27 studies of 
eConsult programs, commonly used modalities were cited as: 
Asynchronous: Communication between health care professionals that is not simultaneous and usually 
occurs within a shared electronic health record (EHR) or other secure platform, including email 
consultations (Vimalananda et al., 2015). This has been assessed in eConsults more recently to 
determine reliability of recording a clinical examination and forwarding for review by a psychiatrist later.15 
Synchronous: Exchange of information in real time between health care providers or between a specialist, 
PCP, and patient simultaneously (e.g., videoconferencing, telephone consultation). 
 
 
 
 
Figure 1 illustrates the typical pathway of communication in an eConsult. Emerging technology using 
mobile applications on cellular devices may provide additional possibilities in telepsychiatry consultations 
between providers (Mechanic and Kimball, 2019). 
                                                     
15https://www.aacap.org/AACAP/Clinical_Practice_Center/Business_of_Practice/Telepsychiatry/Telehealth_Glossary.
aspx 
In this report, provider-to-provider telehealth consultations are referred to as 
electronic consultations or “eConsults”, and include both synchronous (e.g., 
phone, videoconference) and asynchronous (e.g., email, electronic health record/EHR) 
modalities. A patient may or may not be present during an eConsult. A telehealth 
consultation solely between a provider and a patient is not included in this definition. 
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Figure 1. Basic Steps of a Typical eConsult Between Primary Care Provider and Specialist  
 
Source: Vimalananda et al., 2015. 
Massachusetts Child Psychiatry Access Project (MCPAP) 
One model for a psychiatric eConsult program is the Massachusetts Child Psychiatry Access Project 
(MCPAP). MCPAP was implemented in response to an increase in primary care visits involving mental 
health issues and a shortage of child psychiatric providers (Van Cleave et al., 2015). Provider practices 
enroll in the MCPAP program and then are able to call psychiatrists as needed. Most often, PCPs 
remained the primary provider for patients being treated for mental health issues (Van Cleave et al., 
2015). PCPs contact MCPAP when they see a patient experiencing mental health issues and are 
uncertain about an aspect of care, would like referrals for evaluation by a MCPAP clinician, or require 
advice on interim treatment while awaiting referral (Knutson et al., 2014; Van Cleave et al., 2015).  
MCPAP for Moms 
MCPAP for Moms was established in 2013 and adapted from the model of MCPAP in response to high 
rates of depression during pregnancy and the postpartum period (Byatt et al., 2016). The program is 
comprised of one full-time perinatal psychiatrist and two to three care coordinators to serve the state of 
Massachusetts. Any provider that may have contact with pregnant or postpartum women, including OB-
GYNs, adult PCPs, and general psychiatrists, can call to obtain a consultation with a perinatal psychiatrist 
through MCPAP’s hub for any type of mental health concern. In addition to telephone consultations 
between providers, MCPAP also provides face-to-face consultations with the patient when necessary, 
training and toolkits for providers to promote education, and care coordination to provide the patient with 
community resources (Byatt et al., 2016).  
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Access and timeliness of care 
The goal of psychiatric eConsults is for PCPs to be able to more quickly diagnose and treat mental health 
conditions. In health care research, these outcomes may be measured using access to care and time to 
service indicators. Access to care refers to having use of health care services when they are needed. 
This may include having resources (e.g., health insurance), having the ability to enter the health care 
system and having an appropriate provider available, or having physical access (e.g., transportation) 
(AHRQ, 2014a). Timeliness of care refers to a health care system's capacity to provide care quickly after 
a need is recognized (AHRQ, 2014b). This may include wait times, time to referral to a specialist, or time 
to initial appointment. With respect to appropriate care, eConsults can address a significant obstacle to 
access and service delivery in terms of alignment of patient needs and provider skills related to culture 
and language (Hilty et al., 2018a; 2018b). eConsults can leverage expertise between interdisciplinary 
teams and between different models of care, and they can provide PCPs with consulting clinicians whose 
expertise they can tap. Like patients, PCPs need consultants with broad perspectives, cultural expertise, 
and experience with a variety of populations to adapt practice (Hilty et al., 2018a; 2018b). 
Mental Health Disorder Prevalence in California 
Mental health disorders encompass a wide range of distinct conditions that are associated with varying 
levels of impairment. This section describes the most common mental health conditions in children and 
pregnant and postpartum persons for which an eConsult may be sought by a PCP. Table 1 presents 
California population estimates and rates of each population the bill specifies that may need care for a 
behavioral health condition. Behavioral health includes both mental health conditions and substance use 
disorders (SAMHSA, 2019). 
Table 1. California Population Estimates for Children and Postpartum and Pregnant Persons and 
Estimates for Those who May Need Care for a Behavioral Health Condition, 2017-18 
 Population in CA 
Subject to AB 
1676 (a) 
Percent Who 
Might Need 
Behavioral Health 
Care 
Number Who Might 
Need Behavioral 
Health Care (b) 
Children (≤17)  7,258,480 14-20% 
(c) 1,016,187-1,451,696 
Pregnant and Postpartum 407,000 20% 
(d) 81,400 
Source: California Health Benefits Review Program, 2019.  
(a) CHBRP, 2018.  
(b) Population in CA Subject to AB 1676 multiplied by percent who might need behavioral health care. 
(c) Tyler et al., 2017.  
(d) California Health Care Foundation, 2018.  
Key: CA = California  
Mental Health Disorders and Prevalence in Children 
Mental disorders are some of the most common chronic conditions in children (Anderson et al., 2015), 
with depression/anxiety disorders, autism spectrum disorders, and attention-deficit/hyperactivity disorder 
(ADHD) among the most common diagnoses (CDC, 2019). Pediatric bipolar disorder is another condition 
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for which a PCP might seek expert consultation due to a lack of knowledge about this particular diagnosis 
and treatment.16 
Anxiety and depression and prevalence 
In the U.S., prevalence rates of children with diagnosed anxiety or depression rose between 2003 and 
2011–2012 (Bitsko et al., 2018). For children aged 3–17, 7.1% have a diagnosis of anxiety, while 3.2% 
are diagnosed with depression (CDC, 2019). Prevalence of diagnoses may under-represent the true 
problem; a body of literature exists suggesting that underdiagnosis and undertreatment remain a public 
health problem (Neavin et al., 2018; Polanczyk et al., 2015). One of the challenges with diagnosing 
pediatric major depressive disorder (MDD) is differences in presentation of symptoms compared to adults: 
while most symptoms screened are the same, children may present with irritable mood as opposed to 
depressed mood, may have a drop in grades rather than noticeable lack of concentration, or other 
complex interactions with normal developmental changes (Neavin et al., 2018). Prevalence of anxiety and 
depression diagnoses in youth tend to increase with age (CDC, 2019). 
Autism spectrum disorder and prevalence 
Autism spectrum disorder (ASD) is a developmental disorder that may present with a range of symptoms 
and severities (NIMH, 2018). Children with ASD may have difficulty with social interaction, 
communication, repetitive behaviors, sensitivity to sensory input, and other symptoms that may inhibit 
functionality (NIMH, 2018). ASD is most often identified at a young age (≤6 years) but can be diagnosed 
in older children and adults.  
The Centers for Disease Control and Prevention (CDC) Autism and Developmental Disabilities Monitoring 
Network (ADDM) estimated that in 2014, 1 in 59 children in the U.S. had ASD, a 15% increase from the 
previous estimate in 2012 of 1 in 68 children (Baio et al., 2018). CHBRP previously estimated that in 2016 
the prevalence of ASD in California for children aged 0–9 years old was about 160 in 10,000 (1 in 63) 
(CHBRP, 2017).  
Attention-deficit/hyperactivity disorder and prevalence 
According to the CDC, more than 6.1 million children have been diagnosed with the neurodevelopmental 
disorder ADHD as of 2016 based on the National Survey of Children’s Health (NSCH). Developing ADHD 
is based on multiple factors, such as genetics, perinatal stress, traumatic brain injury, maternal smoking 
and alcohol use during pregnancy, and other environmental conditions (Tandon and Pergjika, 2017). The 
CDC also highlights how parents play a pivotal role in the treatment of their children, especially by 
understanding that seeking out behavior therapy is the first step in supporting their children.  
Pediatric bipolar disorder and prevalence 
Less is known about bipolar disorder in children and adolescents than in the general population. Pediatric 
bipolar disorder (PBD) can be an impairing disorder that affects mood, self-esteem, hypersexual 
behavior, sleep, and other daily activities (Washburn et al., 2011). It is estimated that 2.9% of adolescents 
have a PBD diagnosis, with this rate being slightly higher for females (3.3%) than males (2.6%) (NIMH, 
2017). More work is needed regarding the screening and treatment of PBD because bipolar disorder was 
historically thought to occur following the onset of adolescence, well into adulthood (Renk et al., 2014). 
The prevalence of PBD has dramatically increased in recent years, raising questions of overdiagnosis 
and underdiagnosis (Washburn et al., 2011).  
                                                     
16 Personal communication, Donald Hilty, MD, MBA, Northern California Veterans Affairs, UC Davis, March 26, 2019.  
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Screening recommendations and treatment: Children 
Mental health conditions in childhood are identified by deviations from developmental and emotional 
milestones that would be expected for children of a similar age (Perou et al., 2013). The American 
Academy of Pediatrics has published clinical practice guidelines for the diagnosis, evaluation, and 
treatment of ADHD, which primarily relies on a PCP screening children for academic, behavioral, or 
attention problems; hyperactivity; or impulsivity (Subcommittee on Attention-Deficit/Hyperactivity Disorder, 
2011). These guidelines involve the PCP intentionally to help address the shortage of mental health 
professionals for children (Anderson et al., 2015). In 2018, Cheung and colleagues published updated 
treatment and management guidelines for depression in adolescents, and these also followed the PCP 
model for routine clinical management (Cheung et al., 2018).  
The U.S. Preventive Services Task Force (USPSTF) has published guidance based on reviews of 
diagnosis and treatment practices for pediatric MDD, and annual screening in all adolescent patients 
aged 12–17 is recommended in order to reduce underdiagnosis and to provide treatment more quickly 
(Neavin et al., 2018). Guidance has not been made clear for children younger than age 12 according to 
the current Guidelines for Adolescent Depression in Primary Care and the USPSTF Guidelines 
(Zuckerbrot et al., 2018). 
The American Academy of Child & Adolescent Psychiatry (AACAP) (AACAP, 2017) has also issued 
treatment guidelines for psychiatric illness in children. Of the conditions discussed in this review, the only 
practice parameter currently available is for ASD treatment, although clinical practice guidelines are under 
development by AACAP for ADHD, anxiety, and depression.17 Recommendations for ASD include 
educational and behavioral interventions first, and then pharmacotherapy if indicated for a specific set of 
symptoms or comorbidities (Volkmar et al., 2014). 
Mental Health Disorders and Prevalence in Pregnant and Postpartum Persons 
Maternal mental health (MMH) disorders include a range of distinct disorders that may arise or become 
exacerbated during pregnancy or after birth; in this analysis, we focused on the most common MMH 
disorders (i.e., depression and anxiety) (CA Task Force, 2017). The definition of the postpartum period 
varies somewhat between sources, beginning at the birth of the child and ending six weeks to one year 
later (Biebel et al., 2015; CA Task Force, 2017). This description focuses on mental health disorders 
among pregnant or postpartum women, although research has shown that postpartum mental health 
conditions can also occur in men and adoptive parents (Foli et al., 2013; Ngai and Ngu, 2015; Wong et 
al., 2017).  
Maternal depressive disorders and prevalence  
Perinatal depression encompasses both MDD and minor depression (CA Task Force, 2017; Gavin et al., 
2005). To receive a diagnosis of MDD, women must exhibit low spirits/mood, persistent sadness, 
indifference, feelings of inadequacy, and/or anxiety for most of the day for at least 2 weeks; changes in 
sleep, appetite, energy, and/or concentration; and/or possible suicidal ideation/actions (including 
psychotic features, though very rare) with varying levels of severity ranging from mild to severe (CA Task 
Force, 2017). Mild depression is characterized as having similar symptoms as MDD; however, the 
number and duration of symptoms occur with less frequency (CA Task Force, 2017).  
                                                     
17 
https://www.aacap.org/AACAP/Resources_for_Primary_Care/Practice_Parameters_and_Resource_Centers/Practice
_Parameters.aspx  
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Perinatal depression is a common MMH disorder in the U.S. with an estimated prevalence rate of 13% 
(Hahn-Holbrook et al., 2018). Specific to California, the overall prevalence of perinatal depressive 
symptoms was 20.5% in 2013; prevalence rates for prenatal compared to postpartum depression (PPD) 
were similar, at 14.9% and 12.8% respectively, with 7.2% of California women experiencing both (CA 
Task Force, 2017; Caldwell and Forquer, 2015).  
Maternal anxiety disorders and prevalence  
With reported rates of up to 20% prevalence among women, perinatal anxiety is the most common MMH 
disorder (Fairbrother et al., 2016) and includes four distinct conditions: (1) generalized anxiety disorder, 
(2) panic disorder, (3) obsessive compulsive disorder, and (4) perinatal post-traumatic stress disorder 
(PTSD) (CA Task Force, 2017). A meta-analysis of maternal anxiety across 34 countries found that the 
prevalence of clinical diagnoses of any anxiety disorder was 15.2% during pregnancy and 9.9% in the first 
6 months after giving birth (Dennis et al., 2017).  
To receive a diagnosis of generalized anxiety disorder, an individual must exhibit 6 or more months of 
excessive worry on a day-to-day basis — on most days — with accompanying physiological symptoms 
with varying levels of severity ranging from mild to severe (CA Task Force, 2017). Panic disorder is 
characterized as recurring episodes of panic attacks in which an individual exhibits 10 to 15 minutes of 
intense anxiety paired with physiological symptoms such as a racing heartbeat, sweaty palms, and 
shortness of breath that impair regular function (CA Task Force, 2017). Obsessive-compulsive disorder is 
described as intrusive thoughts leading to anxiety (i.e., obsessions), followed by behaviors — often rigid 
or ritualistic — aimed to diminish obsessive thoughts (i.e., compulsions) (CA Task Force, 2017). Perinatal 
PTSD results from perceived traumatic birth experiences and may include flashbacks, nightmares, 
increased arousal, anxiety, or a feeling of detachment (CA Task Force, 2017). 
Screening recommendations and treatment: Pregnant and postpartum persons 
In January 2016, the USPSTF released an updated recommendation for screening for depression in the 
general population, including pregnant and postpartum women (Siu et al., 2016). To align benefits and 
services with expert recommendations, the Centers for Medicaid & Medicare Services (CMS) issued 
guidance in May 2016 (CMS, 2016), to announce the provision and coverage of maternal depression 
screening during well-child visits given the lasting impacts untreated maternal depression may have on an 
infant (Wachino, 2016).  
According to the CA Task Force, women should be educated on the various MMH disorders and be 
assessed for risk prior to pregnancy and several times throughout their reproductive years (CA Task 
Force, 2017). Furthermore, women should be screened at least once during the perinatal period. During 
preconception, pregnancy, and/or postpartum, the CA Task Force advises that a woman’s health care 
provider conduct a mental health assessment and screening for depression, anxiety, and bipolar 
disorders (CA Task Force, 2017). In addition to screening for MMH disorders, a discussion should be held 
regarding MMH risk factors such as mental health history, family history of MMH disorders, and general 
health promotion (e.g., healthy diet to support a growing fetus, sufficient sleep, adequate physical 
activity).  
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Disparities18 and Social Determinants of Health19 in Mental Health Disorders 
Per statute, CHBRP includes discussion of disparities and social determinants of health (SDoH) as it 
relates to mental health disorders. Disparities are differences between groups that are modifiable. 
CHBRP found literature identifying disparities by race/ethnicity for children, and by race/ethnicity, gender, 
and age for pregnant and postpartum persons. 
Disparities for Children 
Race and ethnicity 
Although prevalence studies indicate few racial/ethnic differences in mental health disorders, diagnosis 
and treatment have been shown to have more of these disparities, particularly in African American and 
Latino children (Alegria et al., 2011; Liang et al., 2016). These differences are problematic in that potential 
misdiagnoses in youth mental health conditions could result in unmet needs or inappropriate care. In a 
review article of 72 studies, African American youth were more likely to be diagnosed with psychotic and 
disruptive behavioral disorders than with mood or substance abuse disorders, while Hispanic youth were 
more likely to be diagnosed with disruptive behavior and substance abuse disorders than with ADHD; 
Asian youth were also less likely to be diagnosed with ADHD (Liang et al., 2016). Additionally, there is 
some evidence of racial/ethnic disparities with regard to delays in diagnosis, specifically for ASD in 
African American children (Alegria et al., 2011) and in medication use for ADHD in African American and 
Latino children (Coker et al., 2016). The disparities in medication use seem to suggest that these 
differences may be more related to underdiagnosis and undertreatment of minority youth rather than 
overtreatment of white youth (Coker et al., 2016). 
Disparities for Pregnant and Postpartum Women 
Race and ethnicity 
African American and Hispanic/Latina women are more likely to have symptoms of maternal depression 
but are also more likely to receive a prenatal depression screening compared to white and Asian women 
(CA Task Force, 2017; Caldwell and Forquer, 2015; CDPH, 2016). Despite higher rates of symptoms and 
access to screenings, minority women have lower rates of successful linkages to MMH services.21 In a 
U.S.-based study examining utilization of mental health services among publicly insured white and African 
American pregnant and postpartum women, researchers found that African American women had a 50% 
lower probability of using available services than white women.  
Gender and age 
Across the U.S., perinatal depression is about three times as common among women compared to men, 
with approximately 11% of women experiencing postpartum depressive symptoms compared to 4% of 
new fathers experiencing depressive symptoms in the first year of their child’s birth (Davé et al., 2010; Ko 
                                                     
18 Several competing definitions of “health disparities” exist. CHBRP relies on the following definition: 
Health disparity is defined as the differences, whether unjust or not, in health status or outcomes within a population. 
Wyatt et al., 2016. 
19 CHBRP defines social determinants of health as conditions in which people are born, grow, live, work, learn, and 
age. These social determinants of health (economic factors, social factors, education, physical environment) are 
shaped by the distribution of money, power, and resources and impacted by policy (adapted from Healthy People 
2020, 2015; CDC, 2014). See CHBRP’s SDoH white paper for further information: 
http://chbrp.com/analysis_methodology/public_health_impact_analysis.php. 
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et al., 2017). As previously mentioned, pregnancy and postpartum hormonal shifts have also been 
attributed to the increased risk of MMH disorders in perinatal women (Marcus, 2009; O'Hara and 
McCabe, 2013). In a study evaluating the relationship between maternal age and depression, researchers 
found that postpartum women of advanced maternal age (i.e., aged 40 to 44 years) had a significantly 
higher risk for PPD compared to younger women (aged 30 to 35 years) with an adjusted odds ratio of 
3.72 (Muraca and Joseph, 2014). At the other end of the age range for childbearing women, adolescent 
and young adult mothers with unintended pregnancy may also be at greater risk for MMH issues; one 
study of nationally representative data from the National Longitudinal Study of Adolescent to Adult Health 
found they were 1.21 times more likely to have perinatal depressive symptoms compared to those in the 
same age range who had intended to become pregnant (Hall et al., 2017).  
Social Determinants of Health  
Social determinants of health (SDoH) include factors outside of the traditional medical care system that 
influence health status and health outcomes (e.g., income, education, geography). CHBRP found 
literature on how socioeconomic status, stigma, and geography may impact prevalence of MMH disorders 
and access to MMH screening and treatment.  
Socioeconomic status  
Socioeconomic status (SES) may be a significant factor in disparities in maternal depression among 
women of color compared to white women and among mothers who are younger (i.e., teenage/young 
adult) or facing an unplanned or first-time pregnancy compared to mothers who are slightly older, have 
planned pregnancies, or have other children already. These groups of women may face additional life 
stressors related to lower income or less financial stability, which may heighten symptoms of depression 
and anxiety (Goyal et al., 2010; Leathers and Kelley, 2000). Compared to women with higher SES, 
women with low SES may also be more likely to experience domestic violence (Brown et al., 1999; 
Escribà-Agüir et al., 2013), have significant childhood trauma (Blalock et al., 2013), and have 
acute/chronic stressors and physical conditions such as a lack of social support, diabetes, or a mental 
health disorder prior to pregnancy, all of which are linked to higher rates of maternal depression (Song et 
al., 2004; Walmer et al., 2015).  
Barriers to accessing MMH care are also greater for women of low SES compared to those with high 
SES, which may explain in part why women of color and women with Medi-Cal coverage have higher 
rates of maternal depression and are less likely to have a postpartum visit compared to white women and 
women with private insurance (DiBari et al., 2014). A systematic review regarding access to MMH care 
among low income women in western countries found that a lack of transportation, homelessness or poor 
housing conditions, and concerns over the cost of MMH care represent significant barriers (Hansotte et 
al., 2017). Furthermore, women with Medi-Cal coverage due to pregnancy status but who otherwise do 
not meet eligibility requirements lose coverage 60 days postpartum, presenting additional barriers to 
MMH care (de Bocanegra et al., 2017). Even among those who had health insurance, concerns or 
perceptions that mental health care would not be covered hindered access to MMH care for low-income 
women (Hansotte et al., 2017).  
Stigma  
Mental health stigma is a significant barrier to accessing MMH care, as concerns about being judged for 
having a mental illness may be compounded by fears of being perceived as being an unfit mother, or in 
some cases, fears that reaching out to a medical professional for help will lead to involuntary 
hospitalization or a report to Child Protective Services (CA Task Force, 2017). A survey of 291 women at 
a community clinic in North Carolina found that beliefs and concerns about talking to their doctor about 
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potential MMH disorder symptoms would prevent disclosure from taking place for 19% of women 
surveyed, reflecting the role of internalized stigma (e.g., feeling ashamed or like a bad mother for having 
mental health issues) and social stigma (e.g., fearing that reporting symptoms will lead to poor regard or 
treatment, or reports to Child Protective Services) and how they can impact access to care (Prevatt and 
Desmarais, 2018). These findings were echoed in a systematic review regarding access to MMH care 
among low income women in western countries, which reported that stigma was a major barrier (Hansotte 
et al., 2017). The review also indicated that stigma may be especially detrimental to some racial/ethnic 
and immigrant minorities who may feel pressured by religious beliefs to accept how they feel during 
pregnancy and not seek help, which presents a significant barrier to accessing care or speaking to a 
provider about these issues (Hansotte et al., 2017).  
Health literacy  
A lack of knowledge or awareness of how women may be affected by mental health disorders during 
pregnancy or postpartum may prevent women from recognizing symptoms in themselves or knowing what 
to do or where to go to access care (Hansotte et al., 2017). Health literacy issues in regard to seeking 
and obtaining care for MMH conditions are especially prevalent among women with limited English-
speaking ability (e.g., recent immigrant women or women from insular immigrant communities) or lower 
educational attainment (Hansotte et al., 2017).  
Geography 
Geographical isolation due to living in an area with fewer mental health or reproductive health care 
providers also limits access to care; transportation can be an issue for women living in rural or urban 
areas, as rural-living women may have further distances to travel to access care, while women living in 
low-income urban areas may not have providers in an accessible area or face poor public transportation 
systems (CA Task Force, 2017; Hansotte et al., 2017).  
A recent report on behavioral health professionals in California highlights the lack of mental health 
providers in rural areas of the state. The findings indicate very low per capita ratios of psychiatrists, 
particularly in the San Joaquin Valley (7.1 per 100,000 population) and Inland Empire (7.7 per 100,000 
population) regions. This is well below the statewide average of 14.7 licensed psychiatrists per 100,000 
population. The region with the greatest density of psychiatrists for the population is the Greater Bay Area 
(Coffman et al., 2018). eConsults between a PCP and psychiatrist may play a greater role in diagnosing 
and treating behavioral health conditions in areas with fewer psychiatrists (Hilty et al., 2007). 
Societal Impact of Mental Health Disorders in California 
The presence of MMH issues in California and the U.S. creates a societal impact. In dollar terms, the 
societal impact can be indirect (e.g., lost wages, productivity) as well as direct (medical care). The CA 
Task Force used findings from 2010 to estimate that California’s annual indirect costs of untreated 
maternal depression was approximately $2.25 billion, based on $7,200 in productivity loss for the mother 
and $15,300 in costs incurred due to poor child developmental and behavioral outcomes and subsequent 
impacts on the child’s education and productivity (CA Task Force, 2017; Diaz and Chase, 2010). 
Adjusting for inflation, this would be $8,359 for the mother and $17,762 for the child in 2019 dollars, for a 
total of $26,121 per mother-child pair per year. Please note, the societal impact discussed here is 
relevant to a broader population than AB 1676 impacts, since it would affect the health insurance of a 
subset of Californians (see the Policy Context section). In addition, the Benefit Coverage, Utilization, and 
Cost Impacts section estimates cost impacts on payers. Such figures represent a subset of the total 
societal impact related to MMH issues. 
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Children diagnosed with ASD have a significant economic impact on families in the U.S.; total estimated 
costs range from $11.5 billion to $60.9 billion (2011 US dollars), which includes direct and indirect costs 
such as medical care, special education, lost parent productivity, and intensive behavioral interventions 
(Buescher et al., 2014; Lavelle et al., 2014). 
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MEDICAL EFFECTIVENESS 
As discussed in the Policy Context section, AB 1676 would require health plans and health insurers, by 
January 1, 2021, to establish a telehealth consultation program that provides providers who treat children 
and pregnant and postpartum persons with access to a psychiatrist, as specified, in order to more quickly 
diagnose and treat children and pregnant and postpartum persons suffering from mental illness. 
Additional information on telepsychiatry consultation programs for providers treating children and 
pregnant and postpartum persons for mental health conditions is included in the Background section. The 
medical effectiveness review summarizes findings from evidence20 on the effectiveness of psychiatric 
eConsults, both synchronous and asynchronous, and specifically for the treatment of children and 
pregnant and postpartum persons.  
 
 
 
Research Approach and Methods 
Studies of psychiatric eConsults were identified through searches of PubMed, the Cochrane Library, Web 
of Science, the Cumulative Index of Nursing and Allied Health Literature, and PsycINFO. Websites 
maintained by the following organizations that produce and/or index meta-analyses and systematic 
reviews were also searched: the Agency for Healthcare Research and Quality (AHRQ), the International 
Network of Agencies for Health Technology Assessment (INAHTA), the National Health Service (NHS) 
Centre for Reviews and Dissemination, the National Institute for Health and Clinical Excellence (NICE), 
and the Scottish Intercollegiate Guideline Network. The Massachusetts Child Psychiatry Access Program 
(MCPAP) website and available resources were also searched as pertinent to this bill and reviewed. 
The search was limited to abstracts of studies published in English. The search was limited to studies 
published from 2004 to present. Of the 51 articles found in the literature review, 33 were reviewed for 
potential inclusion in this report on AB 1676, and a total of six studies were included in the medical 
effectiveness review. The other articles were eliminated because they did not focus on a specific 
treatment or population, were of poor quality, or did not report findings from clinical research studies. A 
more thorough description of the methods used to conduct the medical effectiveness review and the 
process used to grade the evidence for each outcome measure is presented in Appendix B. 
The conclusions below are based on the best available evidence from published peer-reviewed and grey 
literature.  
Key Questions 
1. Are psychiatric eConsults effective in the mental health treatment of: 
                                                     
20 Much of the discussion below is focused on reviews of available literature. However, as noted on page 11 of the 
Medical Effectiveness analysis and research approach document (posted here), in the absence of “fully-applicable to 
the analysis” peer-reviewed literature on well-designed randomized controlled trials (RCTs), CHBRP’s hierarchy of 
evidence allows for the inclusion of other evidence. 
In this report, provider-to-provider telehealth consultations are referred to as 
electronic consultations or “eConsults”, and include both synchronous (e.g., phone, 
videoconference) and asynchronous (e.g., email, electronic health record/EHR) 
modalities. A patient may or may not be present during an eConsult. A telehealth 
consultation solely between a provider and a patient is not included in this definition. 
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a. Adults (generally) 
b. Specific populations: 
i. Children 
ii. Pregnant or postpartum persons  
Methodological Considerations 
The primary focus of this review and analysis will be on psychiatric eConsults, not telehealth services 
provided directly to patients, as specified in the bill language. Additionally, this bill specifies mental health 
treatment of children and pregnant and postpartum persons. CHBRP identified no rigorous studies that 
addressed the use of psychiatric eConsult programs to treat these specific populations. This review 
includes an analysis of studies of psychiatric eConsult programs for adults in general, in order to provide 
some context on effectiveness.  
Outcomes Assessed 
The primary outcomes of interest are receipt of appropriate care, patient mental health outcomes (e.g., 
measures of depression and anxiety) and quality of life, provider knowledge and skill development for 
mental health treatment, provider and patient satisfaction, and timeliness of services.  
Study Findings21 
This section summarizes CHBRP’s findings regarding the strength of evidence for the effectiveness of 
psychiatric eConsults for mental health treatment, specifically for children and pregnant and postpartum 
persons as addressed by AB 1676. Separate charts are presented for general population effectiveness 
and the specific populations for which the bill would mandate coverage — children and pregnant and 
postpartum persons.  
Although there is a larger body of literature on general telehealth services for mental health, CHBRP 
found limited evidence on the effectiveness of psychiatric eConsults generally and insufficient evidence 
on the effectiveness of psychiatric eConsults specifically for children and pregnant and postpartum 
persons. It should be noted that a grading of insufficient evidence is given when there is an absence of 
robust, high-quality studies available in the literature. This does not mean there is no effect; it means that 
the effect is unknown.  
Effectiveness of Psychiatric eConsults  
Electronic consultation (eConsult) has been shown to improve timely access to care for a number of 
medical subspecialties (Horner et al., 2011; Liddy et al., 2016). eConsults generally involve a PCP referral 
for a consultation to discuss questions about a patient’s care that is outside of their expertise. eConsults 
                                                     
21 The following figures in this section summarize CHBRP’s findings regarding the strength of the evidence for the 
effects of psychiatric eConsults addressed by AB 1676. For test, treatments, and services for which CHBRP 
concludes that there is clear and convincing, preponderance, limited, or inconclusive evidence, the placement of the 
highlighted box indicates the strength of the evidence. If CHBRP concludes that evidence is insufficient, a figure that 
states “Insufficient Evidence” will be presented. 
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with psychiatrists and mental health providers have resulted from PCPs experiencing difficulty in treating 
or referring patients for specialty mental health care for problems that are often first encountered and 
addressed in a primary care setting (Lowenstein et al., 2017). The scientific literature regarding the 
effectiveness of psychiatric eConsults on provider and patient outcomes has reported positive findings, 
although the studies have been predominately descriptive in nature (Hilty et al., 2018). Research in this 
area is beginning to shift toward randomized controlled trials (RCTs) to better assess these outcomes 
(Hilty et al., 2018).  
A review of telehealth services for mental health reported on the effectiveness of psychiatry and mental 
health eConsults to PCPs (Hilty et al., 2013). This review included studies that involved a combination of 
specialists, including psychiatrists, psychologists, and mental health specialists, as well as both specialist-
to-provider and specialist-to-patient models; therefore, the overall findings may not apply specifically to 
psychiatric eConsults. The review reported that specialists corrected diagnoses in 91% of cases and 
adjusted medications in 57% of cases. The authors reported clinical improvement in 56% of cases. 
Provider knowledge and skills showed improvement over time with this model of care, particularly in rural-
based PCPs. One of the most pertinent studies included in this review was a case series study that 
reported on data from the Physician Assistance, Consultation, and Training Network (PACT Net), a 
“warm-line” that provided primarily phone access to a variety of specialists, including psychiatrists, to 
assist PCPs in the treatment of patients (adults and children) with developmental disabilities in rural 
California (Hilty, Ingraham, Yang, & Anders, 2004). Data from 30 consultations provided through PACT 
were reviewed and showed that psychiatry was one of the top three eConsult services requested. PCPs 
also provided satisfaction ratings on a 7-point Likert scale of the services they received, which indicated 
that PCPs were not satisfied with pre-existing local services (mean = 3.37) and had overall high 
satisfaction with the quality and usefulness of the eConsults (mean = 6.2). It should be noted that there 
are limitations to the generalizability of these findings given that it was a case series study with no 
comparison group.  
In another case series study focused on telepsychiatry to rural areas, 400 patients received an initial 
telepsychiatry consultation provided primarily by videoconference by the University of California Davis 
Health System’s (UCDHS) telemedicine department and used a model of care in which the PCP typically 
participated during the last 5-10 minutes of the consultation (Hilty et al., 2006). The intervention also 
included comprehensive educational components for the PCPs. The study assessed improvement in 
PCPs’ knowledge and skills through improvements in medication dosing. The researchers reported that 
PCPs significantly improved medication dosing over time from 47.4% accuracy among the first 200 
consultations to 63.6% accuracy in the second 200 consultations (p<.001). PCPs reported high overall 
satisfaction with the program and quality of the consultation (4.61 and 4.62, respectively, on average on a 
5-point Likert scale). As noted above, there are limitations to the generalizability of findings given that this 
study was a case series study with no comparison group. Additionally, the PCPs were selected for the 
study based on being established frequent users of UCDHS’s telemedicine services. As noted by the 
authors, this may not be representative and may have led to more use of the consultation program.  
Timeliness of services and providing appropriate care are outcomes that could be expected to be 
impacted by the use of psychiatric eConsults. Timely delivery of appropriate care is recognized by AHRQ 
as a key dimension of care to improve health outcomes and quality of life (AHRQ, 2017). A retrospective 
study conducted by Archibald et al. (2018) in Canada, reviewed 5,597 eConsults directed to psychiatry by 
PCPs and reported on time to receive services, adjustment of treatment plans, and satisfaction. The 
majority of the eConsults reviewed in this study were asynchronous. The researchers reported the 
average response time to be approximately 3.2 days and that the consults took less than 15 minutes on 
average for the psychiatrist to complete. The PCPs noted in the evaluation that the eConsult response 
time was much shorter than for traditional referrals. The majority of PCPs indicated in post eConsult 
surveys that the advice they received from the psychiatrist directed them to a new or additional course of 
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action for the patient’s treatment plan (62.1%), and 30.7% of the eConsults eliminated the need for a 
patient referral to a psychiatrist. Overall, PCPs were highly satisfied and believed that the program was 
valuable (88.7%).  
Lowenstein et al. (2017) performed a case series study of the University of California, San Francisco’s 
eConsult program, which includes psychiatry along with eight other subspecialties. The researchers 
performed a content analysis of the first 50 eConsults to psychiatry that the program received after 
implementation and also reported on time to receive services, treatment implementation, and satisfaction. 
The content of the email question and answer exchange between the providers was included in and 
retrieved from the EHR for review. They reported that the psychiatrists were able to address all requested 
consults and that the average response time was 1.4 days. For comparison, they report the average wait 
time for an in-person consult with the hospital’s psychiatry practice was 46 days. The PCPs implemented 
the treatment recommendations provided by the psychiatrist in 76% of consults. The study found that the 
majority of consults were sufficient to support the patient’s care without need for in-person referral (74%) 
and that this was especially true for patients with depression and anxiety.  
Summary of findings: There is limited evidence from one review on telehealth services for mental 
health, one case series study on telepsychiatry, and two case series studies on psychiatric eConsult 
programs that psychiatric eConsults are effective at improving appropriate treatment of mental health 
conditions as measured by improvement in the receipt of more appropriate care and mental health 
outcomes in patients, provider knowledge and skill development for mental health treatment, provider 
satisfaction, and  timeliness of services. 
 Figure 2. Effectiveness of Psychiatric eConsults  
 
Effectiveness of Psychiatric eConsults for Children’s Mental Health Treatment   
CHBRP identified one case study of MCPAP that examined pediatric PCPs’ ability to meet the psychiatric 
needs of their clients (Straus & Sarvet, 2014). MCPAP is a system designed to help PCPs meet the 
needs of children with any behavioral health problem via remote hubs located at an academic medical 
center; these hubs consist of child psychiatrists, a licensed therapist, and a care coordinator who are 
available by phone. This model treats every consultation as an opportunity to educate PCPs. MCPAP 
also offers face-to-face consultations to clarify any ambiguous diagnoses or to assist with care 
management for children who are not responding to treatment. MCPAP collects data from encounters 
between the consultant and the PCP, and through satisfaction surveys completed by the PCPs. The case 
study of MCPAP showed an increase in provider knowledge as perceived by the consultants, referrals to 
behavioral health services, and ability to provide appropriate care. Only 8% of providers indicated that 
they could meet the needs of children with behavioral health problems before they enrolled in MCPAP, 
and this increased to 64% after enrollment. The providers involved in the program also reported high 
satisfaction (mean response 4.2 out of 5).  
Summary of findings: There is insufficient evidence from a single case study of one program with no 
comparison group to ascertain the effectiveness of psychiatric eConsults for the mental health treatment 
of children. 
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Figure 3. Effectiveness of Psychiatric eConsults – Children   
 
Effectiveness of Psychiatric eConsults for the Mental Health Treatment of Pregnant or 
Postpartum Persons 
CHBRP did not identify any literature on the effectiveness of the provision of psychiatric eConsults for 
pregnant or postpartum persons. Two studies were identified that reported on the effectiveness of 
MCPAP for Moms. One of these studies (Byatt et al. 2018b) reported on implementation of a program 
that included psychiatric eConsults, along with additional educational components, and was excluded 
from this review because only utilization outcomes were assessed. The second study is provided for 
context although it includes programs comprised of multiple components without addressing eConsults 
alone (Byatt et al., 2018a). This study compared the effectiveness of MCPAP for Moms to the PRogram 
In Support of Moms (PRISM). These programs both included provider access to perinatal psychiatrists via 
telephone or face-to-face, along with training, toolkits, and community-based mental health resources and 
referrals. PRISM included some additional training and implementation and change management support. 
MCPAP for Moms and PRISM both resulted in significant decreases in depression scores on the 
Edinburgh Postnatal Depression Scale (p=0.010 and p=.001, respectively).  
Summary of findings: CHBRP did not identify any literature evaluating the effectiveness of psychiatric 
eConsults regarding the mental health treatment of pregnant or postpartum persons; therefore, there is 
insufficient evidence on the effectiveness of psychiatric eConsults for the mental health treatment of 
pregnant or postpartum persons. 
Figure 4. Effectiveness of Psychiatric eConsults – Pregnant or Postpartum Persons 
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BENEFIT COVERAGE, UTILIZATION, AND COST IMPACTS 
As described in the Policy Context section, AB 1676 would require DMHC-regulated health plans and 
CDI-regulated policies to establish a telehealth consultation program that provides providers who treat 
children and pregnant and postpartum persons with access to a psychiatrist; notify their providers about 
the program twice a year; and keep track of the utilization. This section reports the potential incremental 
impacts of AB 1676 on estimated baseline benefit coverage, utilization, and overall cost.  
 
 
 
 
Key assumptions:  
• CHBRP assumes that AB 1676 would impact a primary care provider’s (PCP’s) access to a 
psychiatrist for inter-professional telehealth consultations (“eConsults”).  
• The bill requires DMHC-regulated plans and CDI-regulated policies to make a psychiatric 
eConsult program available to PCPs but is silent regarding payment or coverage requirements. 
CHBRP interprets that AB 1676 is not a typical mandate bill in that it is not requiring coverage of 
a specific benefit. Therefore, CHBRP does not model an effect in terms of coverage. 
• CHBRP assumes that the administrative costs for establishing and maintaining such a program, 
including the requirements for written notifications and maintenance of data records on the 
program, may vary by plans/policies. CHBRP typically estimates that the increase in 
administrative costs of DMHC-regulated plans and CDI-regulated policies will remain proportional 
to the increase in premiums.  
Baseline and Postmandate Benefit Coverage 
CHBRP conducted a survey of the largest (by enrollment) providers of health insurance in California 
regarding their provision of a psychiatric eConsult program. The survey asked whether such a program 
was available and how it is being provided (e.g., contracted out to a vendor, provided by staff). Currently, 
74% of enrollees with health insurance that can be subject to state mandates and 38% of enrollees with 
Medi-Cal Managed Care coverage subject to AB 1676 are already enrolled in health insurance plans or 
policies where their providers have access to a psychiatric eConsult program. 
Seven of the eight largest commercial plans and all five of the largest MCPs responded to the survey. 
Plans responding to this survey represent 89% of enrollees with private market health insurance that can 
be subject to state mandates and 59% of enrollees with Medi-Cal Managed Care coverage subject to AB 
1676. For those health plans and insurers with psychiatric eConsult programs, psychiatrists are usually 
available via phone, video-conference, and email consultation to all outpatient providers regardless of 
specialty. Psychiatrists are also available via phone and/or in person 24/7 to provide consultation to 
emergency departments and other hospital providers. These telepsychiatry consultation programs can 
involve provider-to-provider consults with or without a patient present.  
In this report, provider-to-provider telehealth consultations are referred to as 
electronic consultations or “eConsults”, and include both synchronous (e.g., phone, 
videoconference) and asynchronous (e.g., email, electronic health record/EHR) 
modalities. A patient may or may not be present during an eConsult. A telehealth 
consultation solely between a provider and a patient is not included in this definition. 
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Postmandate, CHBRP assumes that health plans and insurers without psychiatric eConsult programs will 
need to establish one. Health plans and insurers could provide a telepsychiatry consultation program for 
PCPs through a third-party vendor (e.g., InSight, eVisit), in-network psychiatrists, or some other 
approach. As mentioned above, the bill is silent regarding payment or coverage requirements for such a 
program. CHBRP interprets that AB 1676 is not a typical mandate bill, which would require coverage of a 
specific benefit. Therefore, CHBRP does not anticipate an impact on coverage.  
Utilization 
As stated, CHBRP does not model benefit changes because the bill does not require coverage of a 
benefit available to enrollees but rather requires health plans and insurers to make a psychiatric eConsult 
program available to PCPs. Also, current estimates of utilization of psychiatric eConsults is not available 
given limitations in coding and data sources.  
It is possible that the implementation of AB 1676 would create a shift in utilization from patient in-person 
or provider-to-patient telehealth consultation to eConsults. It is also possible that there could be an 
indirect effect on the overall utilization of psychiatric services. As a result of AB 1676, more enrollees with 
mental health care needs may have increased access to psychiatrist services including medications and 
psychotherapy through their PCPs as a result of a psychiatric eConsult program, but CHBRP is not able 
to quantify these indirect effects. Results from similar programs in Massachusetts may be illustrative. A 
published study of MCPAP for MOM found that the program served 3,599 women, which is about 9.9% of 
women presumed with depression in the first 3.5 years of inception (N. Byatt et al., 2018). For MCPAP 
(for children), there were 6,526 calls from 993 providers in the first 10 months of the program, with an 
average of 6.6 calls per provider (Van Cleave, Holifield, & Perrin, 2018).  
As mentioned in the Medical Effectiveness section, the studies in this emerging field found that 
psychiatric eConsults were a feasible way to support PCPs in managing complex psychiatric issues in the 
primary care setting (Archibald et al., 2018). This study found, for the majority of patients, particularly 
those with depression and anxiety, the consulting psychiatrist supported ongoing management of patients 
within a primary care setting without requesting an in-person psychiatric evaluation and provided a range 
of strategies that facilitated ongoing primary care-based treatment. PCPs using the service frequently 
implemented at least one of the recommendations from the psychiatrist (Lowenstein, 2017). In addition, 
eConsults provided consultation that circumvented common barriers to mental health treatment, including 
access to treatment providers and insurance coverage (Lowenstein, 2017). A review of telehealth 
services for mental health also reported on the effectiveness of psychiatric eConsults for PCPs that 
showed increased access to psychiatrists’ expertise by providers, particularly in rural areas (Hilty et al., 
2013). eConsults may lead to more PCPs referring their patients with mental health needs to psychiatrists 
for care. If that occurs, the overall utilization of psychiatric and other mental health services may increase.  
Expenditures 
As stated above, CHBRP does not model benefit changes because the bill does not require coverage of a 
benefit available to enrollees but rather requires a psychiatric eConsult program available to PCPs. Based 
on such a program in Massachusetts discussed earlier, MCPAP for Moms, costs total about $850,000 per 
year (Byatt, 2017). As mentioned above, it is possible that the implementation of AB 1676 would create a 
shift in utilization from patient in-person or provider-to-patient telehealth consultation to eConsults. 
However, it could also increase referrals of patients to psychiatrists, which will increase overall utilization 
of psychiatric services. If that happens, it may impact overall cost; however, the effect is unknown.  
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Generally, CHBRP comments on the effects of the per-unit cost of services affected by the bill. CHBRP 
estimates that the unit cost for PCP services is unlikely to change following implementation of AB 1676, 
since a provider will continue to bill according to diagnostic and procedure codes for the corresponding 
PCP services. Based on responses to the CHBRP carrier survey, psychiatric consultants could be 
employed by their medical groups, or through a third-party vendor, or some other approach. MCPAP 
estimates that one full-time equivalent psychiatrist is sufficient for 72,000 live births or 250,000 to 300,000 
children.22 Health plans can also include eConsults in the professional services for which they pay the 
medical groups on a capitated basis. Some health plans or insurers may also contract out the services or 
hire an outside vendor and pay the vendor under a fee-for-service arrangement. California payers, 
providers, and county programs are exploring payment options to reimburse for eConsults. For instance, 
at LA Care Health Plan, specialists are paid $45 per consult (Blue Shield of California Foundation, 2016). 
Based on the American Academy of Pediatrics 2019 Coding and Reimbursement Tip Sheet (AAP, 2019), 
eConsults can be charged about $37 to $73 (see details in Table 2 below).  
Table 2. CPT Codes and Reimbursement Rates for Related Services 
CPT code Service Description Office Facility RVUs (Non-Facility/Facility) 
Online Medical Evaluation 
99444 
Online E/M service provided by physician or 
other qualified health care professional who 
may report E/M services provided to an 
established patient or guardian, not originating 
from a related E/M service provided within the 
previous 7 days, using the Internet or similar 
electronic communication network. 
NA NA NA/NA 
Interprofessional Telephone/Internet/Electronic Health Record Consultations 
99446 
Interprofessional telephone/internet/electronic 
health record assessment and management 
services provided by a consultative physician, 
including a verbal and written report to the 
patient’s treating/requesting physician or other 
qualified health care professional; 5-10 minutes 
of medical consultative discussion and review. 
NA $18.38 NA/0.51 
99447 11–20 minutes of medical consultative discussion and review NA $36.40 NA/1.01 
99448 21–30 minutes of medical consultative discussion and review NA $54.78 NA/1.52 
99449 31 minutes or more of medical consultative discussion and review NA $73.16 
NA/2.03 
 
Transition-Related Services — 100% Medicare Payment, 2019 
99451 
Interprofessional telephone/internet/electronic 
health record assessment and management 
service provided by a consultative physician, 
including a written report to the patient’s 
treating/requesting physician or other medical 
$37.48 $37.48 1.04/1.04 
                                                     
22 Personal email communication – Nancy Byatt, DO, MS, MBA, FAPM, Medical Director, MCPAP for Moms, April 19, 
2019. 
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CPT code Service Description Office Facility RVUs (Non-Facility/Facility) 
qualified health care professional, 5 minutes or 
more of medical consultative time 
99452 
Interprofessional telephone/internet/electronic 
health record referral service(s) provided by a 
treating/requesting physician or other qualified 
health care professional, >16 minutes. 
$37.48 $37.48 1.04/1.04 
Source: AAP, 2019 
Key: RVU = relative value unit  
Postmandate Administrative Expenses and Other Expenses 
Postmandate, CHBRP assumes that health plans and insurers without telepsychiatry consultation 
programs will need to establish one, and that for both new and existing programs, plans and insurers will 
need to notify their providers about the program twice a year and keep track of utilization as specified AB 
1676. Thus, there will be increases in administrative costs. However, CHBRP typically estimates that the 
increase in administrative costs of DMHC-regulated plans and CDI-regulated policies will remain 
proportional to the increase in premiums. CHBRP assumes that if health care costs increase as a result of 
increased utilization or changes in unit costs, there is a corresponding proportional increase in 
administrative costs. All health plans and insurers include a component for administration and profit in 
their premiums. 
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PUBLIC HEALTH IMPACTS 
As described in the Policy Context section, AB 1676 would require health plans and insurers, by January 
1, 2021, to establish a telehealth consultation program that provides providers who treat children and 
pregnant and postpartum persons with access to a psychiatrist, as specified, in order to more quickly 
diagnose and treat those persons suffering from mental illness.  
The public health impact analysis includes estimated impacts in the short term (within 12 months of 
implementation) and in the long term (beyond the first 12 months postmandate). This section estimates 
the short-term impact23 of AB 1676 on psychiatric eConsults for mental health diagnosis and treatment of 
children and pregnant and postpartum persons. See Long-Term Impacts for a discussion of premature 
death, economic loss, and social determinants of health. 
 
Estimated Public Health Outcomes 
As presented in the Medical Effectiveness section, there is insufficient evidence to determine whether 
psychiatric eConsults for mental health treatment of children and pregnant and postpartum persons are 
medically effective. In addition, as presented in the Benefit Coverage, Utilization, and Cost Impacts 
section, CHBRP was not able to estimate the impact that AB 1676 would have on utilization. For these 
reasons, CHBRP concludes that AB 1676 would have an unknown impact on short-term and long-term 
public health impacts and disparities in health outcomes. However, this section discusses some of these 
outcomes qualitatively. 
Incorporating telepsychiatry consultations for PCPs who treat children and pregnant and postpartum 
persons could potentially increase access and timeliness to appropriate mental health care (Lowenstein 
et al., 2017). It is estimated that this change in access would be greatest for rural beneficiaries who may, 
personally or through their PCP, otherwise not have had their mental health concerns addressed by a 
psychiatrist due to shortages of licensed psychiatrists in rural areas (Coffman et al., 2018).  
In the first year postmandate, the public health impact of AB 1676 is unknown due to insufficient evidence regarding 
the effectiveness of psychiatric eConsults for mental health treatment for children and pregnant and postpartum 
persons. Limited evidence exists to suggest that psychiatric eConsults for the adult population overall are effective in 
improving the receipt of more appropriate care and mental health outcomes in patients, provider knowledge and skill 
development for mental health treatment, provider satisfaction, and timeliness of services (see Medical Effectiveness 
section). Insufficient evidence exists to support effectiveness in children or pregnant and postpartum persons; 
however, it stands to reason that the populations specified in AB 1676 would experience the same effectiveness of 
psychiatric eConsults as the general population. Please note that the absence of evidence is not “evidence of no 
effect.” It is possible that an impact — desirable or undesirable — could result, but current evidence is insufficient to 
inform an estimate. Additionally, CHBRP is unable to estimate a change in utilization; therefore, the public health 
impact of AB 1676 is unknown.  
                                                     
23 CHBRP defines short-term impacts as changes occurring within 12 months of bill implementation. 
In this report, provider-to-provider telehealth consultations are referred to as 
electronic consultations or “eConsults”, and include both synchronous (e.g., phone, 
videoconference) and asynchronous (e.g., email, electronic health record/EHR) 
modalities. A patient may or may not be present during an eConsult. A telehealth 
consultation solely between a provider and a patient is not included in this definition. 
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Impact on Disparities24 
Benefit Mandate Structure and Unequal Racial/Ethnic Health Impacts 
As discussed in the Policy Context section, AB 1676 would affect the health insurance of all enrollees in 
health insurance plans regulated by the state that may be subject to any state health benefit mandate 
(i.e., CDI-regulated policies and DMHC-regulated plans, including Medi-Cal MCPs regulated by DMHC). 
CHBRP estimates that AB 1676 would increase providers’ access to specialists proportionally more for 
Medi-Cal beneficiaries compared to commercial plan enrollees, as 74% of enrollees with health insurance 
subject to state mandates and 38% of enrollees with Medi-Cal Managed Care coverage subject to AB 
1676 already have a psychiatric eConsult program in place (see the Benefit Coverage, Utilization, and 
Cost Impacts section).  
CHBRP has previously identified that the racial/ethnic composition of Medi-Cal beneficiaries differs from 
that of persons with commercial health insurance (other persons enrolled in DMHC-regulated plans or 
CDI-regulated policies).25 Specifically, Latinos, African Americans, and Other race/ethnicities have 
disproportionately high representation in Medi-Cal as compared to whites and Asians. Mandates such as 
AB 1676 that impact Medi-Cal more significantly may lead to differences in the coverage and utilization of 
certain services for these beneficiaries; therefore, it may disproportionately affect the Latino, African 
American, or Other racial/ethnic population if the mandate-relevant service is found to be medically 
effective. It is possible that there could be unequal health outcomes for Latino and African American 
beneficiaries relative to whites and Asians; however, CHBRP has found insufficient evidence on the 
effectiveness of psychiatric eConsults for mental health treatment specifically for children and pregnant 
and postpartum persons. In addition, utilization cannot be estimated, so this change cannot be measured.  
The racial/ethnic composition of the two health insurance markets — Medi-Cal beneficiaries enrolled in 
DMHC-regulated plans and commercial enrollees (all other enrollees in DMHC-regulated plans or CDI-
regulated policies) — differs. For this reason, a mandate such as AB 1676 that applies to both markets 
will disproportionately impact Latinos, African Americans, and Other race/ethnicities; however, the specific 
impact on racial/ethnic disparities is unknown. 
 
 
                                                     
24 For details about CHBRP’s methodological approach to analyzing disparities, see the Benefit Mandate Structure 
and Unequal Racial/Ethnic Health Impacts document here: 
http://chbrp.com/analysis_methodology/public_health_impact_analysis.php. 
25 Accessible at 
http://chbrp.com/Benefit%20Mandate%20Structure%20and%20Race%20and%20Ethnicity%20.pdf 
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LONG-TERM IMPACTS 
In this section, CHBRP estimates the long-term impacts26 of AB 1676, which CHBRP defines as impacts 
occurring beyond the first 12 months after implementation. These estimates are qualitative and based on 
the existing evidence available in the literature. CHBRP does not provide quantitative estimates of long-
term impacts because of unknown improvements in clinical care, changes in prices, implementation of 
other complementary or conflicting policies, and other unexpected factors. 
 
 
 
Long-Term Utilization and Cost Impacts 
Little research has been published on the long-term impacts on cost and utilization of psychiatric 
eConsults related to treating the populations specified in the bill for mental health conditions. As 
mentioned in the Benefit Coverage, Utilization, and Cost Impacts section, the consulting psychiatrist 
supports ongoing management of patients within a primary care setting without requesting an in-person 
psychiatric evaluation (Lowenstein, 2017). Alternatively, eConsults may lead to more primary care 
providers (PCPs) referring their patients with mental health needs to psychiatrists for care. It is possible 
that the utilization of psychiatric and other mental health services in both primary care and specialty 
settings may increase over time, but overall health care costs will decrease due to improved access to 
care.  
Long-Term Public Health Impacts 
Some interventions in proposed mandates provide immediate measurable impacts (e.g., maternity service 
coverage or acute care treatments) while other interventions may take years to make a measurable 
impact (e.g., coverage for tobacco cessation or vaccinations). When possible, CHBRP estimates the long-
term effects (beyond 12 months postmandate) to the public’s health that would be attributable to the 
mandate, including impacts on social determinants of health, premature death, and economic loss.  
Insufficient evidence exists on the long-term outcomes of psychiatric eConsults to assist PCPs in treating 
children and pregnant and postpartum persons for mental health conditions. Mental health conditions in 
the population contribute to general economic loss, although it is difficult to estimate losses for these 
specific populations and conditions. 
The literature reviewed for this analysis suggests that there is the potential for PCPs to increase 
knowledge and skills over time with regard to diagnosis and treatment of the mental health conditions 
discussed (see the Medical Effectiveness section). Therefore, it is plausible that over time these providers 
may be better prepared to advise their patients in these matters after obtaining regular access to 
psychiatrists for consultation, resulting in the potential for more prompt diagnosis and treatment, and 
improved patient and provider satisfaction. Further, the literature also indicates that after consultation with 
                                                     
26 See also CHBRP’s Criteria and Guidelines for the Analysis of Long-Term Impacts on Healthcare Costs and Public 
Health, available at http://www.chbrp.org/analysis_methodology/cost_impact_analysis.php. 
In this report, provider-to-provider telehealth consultations are referred to as 
electronic consultations or “eConsults”, and include both synchronous (e.g., phone, 
videoconference) and asynchronous (e.g., email, electronic health record/EHR) 
modalities. A patient may or may not be present during an eConsult. A telehealth 
consultation solely between a provider and a patient is not included in this definition. 
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psychiatrists, a large proportion of mental health diagnoses and treatment plans may be corrected. This 
has the potential to impact patient mental health outcomes immediately and over time. 
Impacts on Disparities and the Social Determinants of Health (SDoH)27  
Geography 
Periodically, health insurance mandates can influence SDoH, which can mediate health inequities. 
Evidence presented in the Background section indicates that there is increased risk for mental health 
issues for residents of rural communities (CA Task Force, 2017; Hansotte et al., 2017), and access to in-
person psychiatric consultations may be limited for providers in rural regions of the state because they 
have fewer psychiatrists per capita than in urban areas. PCPs who access psychiatric eConsults could 
potentially lead to improved outcomes for providers and patients in areas more routinely impacted by 
transportation and geographical barriers. Telepsychiatry consultation programs for providers may help to 
overcome some of the disparities in health care by redistributing knowledge and expertise when and 
where it is needed, including in rural areas of California (Nesbitt, 2012). 
Ultimately, it is unknown whether AB 1676 would reduce disparities in access to psychiatric eConsults by 
ameliorating the effects of certain social determinants of health (e.g., transportation, geography). Barriers 
to care could be reduced for some. 
  
                                                     
27 For more information about SDoH, see CHBRP’s publication Incorporating Relevant Social Determinants of Health 
into CHBRP Benefit Mandate Analyses at 
http://chbrp.com/analysis_methodology/public_health_impact_analysis.php.  
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APPENDIX A  TEXT OF BILL ANALYZED 
On February 25, 2019, the California Assembly Committee on Health requested that CHBRP analyze AB 
1676. 
 
ASSEMBLY BILL No. 1676 
 
Introduced by Assembly Member Maienschein 
February 22, 2019 
 
An act to add Section 1367.626 to the Health and Safety Code, and to add Section 10123.868 to 
the Insurance Code, relating to health care. 
 
LEGISLATIVE COUNSEL'S DIGEST 
 
AB 1676, as introduced, Maienschein. Health care: mental health. 
 
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for licensure and 
regulation of health care service plans by the Department of Managed Health Care and makes a 
willful violation of that act a crime. Existing law also provides for the regulation of health insurers 
by the Department of Insurance. Existing law requires health care service plan contracts and health 
insurance policies that provide hospital, medical, or surgical coverage to provide coverage for the 
diagnosis and medically necessary treatment of severe mental illnesses, as defined, of a person of 
any age. Existing law also requires health care service plans and health insurers, by July 1, 2019, 
to develop maternal mental health programs, as specified. 
 
This bill would require health care service plans and health insurers, by January 1, 2021, to 
establish a telehealth consultation program that provides providers who treat children and pregnant 
and postpartum persons with access to a psychiatrist, as specified, in order to more quickly 
diagnose and treat children and pregnant and postpartum persons suffering from mental illness. 
The bill would require health care service plans and insurers to communicate information relating 
to the telehealth program at least twice a year in writing. The bill would require health care service 
plans and health insurers to maintain records and data pertaining to the utilization of the program 
and the availability of psychiatrists in order to facilitate ongoing changes and improvements, as 
necessary. The bill would exempt certain specialized health care service plans and health insurers 
from these provisions. Because a willful violation of the bill’s requirement by a health care service 
plan would be a crime, the bill would impose a state-mandated local program. 
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The California Constitution requires the state to reimburse local agencies and school districts for 
certain costs mandated by the state. Statutory provisions establish procedures for making that 
reimbursement. 
 
This bill would provide that no reimbursement is required by this act for a specified reason. 
 
DIGEST KEY 
Vote: majority   Appropriation: no   Fiscal Committee: yes   Local Program: yes   
 
BILL TEXT 
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS: 
SECTION 1. 
Section 1367.626 is added to the Health and Safety Code, to read: 
1367.626. (a) In order to more quickly diagnose and treat children and pregnant and postpartum 
persons suffering from mental illness, by January 1, 2021, a health care service plan shall 
establish a telehealth consultation program that provides providers who treat children and 
pregnant and postpartum persons with access to a psychiatrist during standard provider hours, 
which may include evenings and weekends. 
(b) A health care service plan shall communicate information relating to the telehealth program 
and its availability to contracting medical providers who treat children and pregnant and 
postpartum persons, including pediatricians, obstetricians, and primary care providers, at least 
twice a year in writing. 
(c) A health care service plan shall maintain records and data pertaining to the utilization of its 
telehealth consultation program and the availability of psychiatrists in order to facilitate ongoing 
changes and improvements to the program, as necessary. 
(d) This section shall not apply to specialized health care service plans, except specialized 
behavioral health-only plans offering professional mental health services. 
SEC. 2. 
Section 10123.868 is added to the Insurance Code, to read: 
10123.868. (a) In order to more quickly diagnose and treat children and pregnant and postpartum 
persons suffering from mental illness, by January 1, 2021, a health insurer shall establish a 
telehealth consultation program that provides providers who treat children and pregnant and 
postpartum persons with access to a psychiatrist during standard provider hours, which may 
include evenings and weekends. 
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(b) A health insurer shall communicate information relating to the telehealth program and its 
availability to contracting medical providers who treat children and pregnant and postpartum 
persons, including pediatricians, obstetricians, and primary care providers, at least twice a year in 
writing. 
(c) A health insurer shall maintain records and data pertaining to the utilization of its telehealth 
consultation program and the availability of psychiatrists in order to facilitate ongoing changes 
and improvements to the program, as necessary. 
(d) This section shall not apply to specialized health insurers, except specialized behavioral 
health-only insurers offering professional mental health services. 
SEC. 3. 
No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the California 
Constitution because the only costs that may be incurred by a local agency or school district will 
be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or 
changes the penalty for a crime or infraction, within the meaning of Section 17556 of the 
Government Code, or changes the definition of a crime within the meaning of Section 6 of 
Article XIII B of the California Constitution. 
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APPENDIX B  LITERATURE REVIEW METHODS 
This appendix describes methods used in the medical effectiveness literature review conducted for this 
report. A discussion of CHBRP’s system for grading evidence, as well as lists of MeSH Terms, publication 
types, and keywords, follows. 
Studies of the effects of psychiatric eConsults were identified through searches of PubMed, the Cochrane 
Library, Web of Science, the Cumulative Index of Nursing and Allied Health Literature, and PsycINFO. 
Websites maintained by the following organizations were also searched: the Agency for Healthcare 
Research and Quality (AHRQ), the International Network of Agencies for Health Technology Assessment 
(INAHTA), the National Health Service (NHS) Centre for Reviews and Dissemination, the National 
Institute for Health and Clinical Excellence (NICE), the Scottish Intercollegiate Guideline Network, and the 
Massachusetts Child Psychiatry Access Program. 
The search was limited to abstracts of studies published in English. The medical effectiveness search 
was limited to studies published from 2004 to present. The literature on the effectiveness of psychiatric 
eConsults is limited and did not include any randomized controlled trials. The majority of the articles 
returned were case studies of psychiatric and mental health telehealth program implementations.  
Reviewers screened the title and abstract of each citation retrieved by the literature search to determine 
eligibility for inclusion. The reviewers acquired the full text of articles that were deemed eligible for 
inclusion in the review and reapplied the initial eligibility criteria. 
The literature review returned abstracts for 51 articles, of which 33 were reviewed for inclusion in this 
report. A total of six studies were included in the medical effectiveness review for AB 1676.  
Evidence Grading System 
In making a “call” for each outcome measure, the medical effectiveness lead and the content expert 
consider the number of studies as well the strength of the evidence. Further information about the criteria 
CHBRP uses to evaluate evidence of medical effectiveness can be found in CHBRP’s Medical 
Effectiveness Analysis Research Approach.28 To grade the evidence for each outcome measured, the 
team uses a grading system that has the following categories: 
• Research design; 
• Statistical significance; 
• Direction of effect;  
• Size of effect; and 
• Generalizability of findings.  
The grading system also contains an overall conclusion that encompasses findings in these five domains. 
The conclusion is a statement that captures the strength and consistency of the evidence of an 
intervention’s effect on an outcome. The following terms are used to characterize the body of evidence 
regarding an outcome: 
• Clear and convincing evidence; 
                                                     
28 Available at: http://chbrp.com/analysis_methodology/medical_effectiveness_analysis.php..  
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• Preponderance of evidence; 
• Limited evidence; 
• Inconclusive evidence; and  
• Insufficient evidence. 
A grade of clear and convincing evidence indicates that there are multiple studies of a treatment and that 
the large majority of studies are of high quality and consistently find that the treatment is either effective 
or not effective.  
A grade of preponderance of evidence indicates that the majority of the studies reviewed are consistent in 
their findings that treatment is either effective or not effective.  
A grade of limited evidence indicates that the studies had limited generalizability to the population of 
interest and/or the studies had a fatal flaw in research design or implementation. 
A grade of inconclusive evidence indicates that although some studies included in the medical 
effectiveness review find that a treatment is effective, a similar number of studies of equal quality suggest 
the treatment is not effective. 
A grade of insufficient evidence indicates that there is not enough evidence available to know whether or 
not a treatment is effective, either because there are too few studies of the treatment or because the 
available studies are not of high quality. It does not indicate that a treatment is not effective. 
Search Terms (* indicates truncation of word stem) 
1. Telepsychiatry consult  
2. E-mental health consult 
3. Telemental health consult 
4. Telemedicine*[1]*[2]*[3] above  
5. Video conferencing*[1]*[2]*[3] above  
6. Live video*[1]*[2]*[3] above  
7. Telephone*[1]*[2]*[3] above  
8. Online consultations *[1]*[2]*[3] above  
9. Children or pregnant or postpartum persons*[1]*[2]*[3] above 
10. OBGYN*[1]*[2]*[3] above 
11. Pediatricians*[1]*[2]*[3] above  
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CALIFORNIA HEALTH BENEFITS REVIEW PROGRAM 
COMMITTEES AND STAFF 
A group of faculty, researchers, and staff complete the analysis that informs California Health Benefits 
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